Evaluation of Cancer Cell Lines by Four-Point Probe Technique, by Impedance Measurements in Various Frequencies

Biosensors (Basel). 2021 Sep 18;11(9):345. doi: 10.3390/bios11090345.

Abstract

Cell-based biosensors appear to be an attractive tool for the rapid, simple, and cheap monitoring of chemotherapy effects at a very early stage. In this study, electrochemical measurements using a four-point probe method were evaluated for suspensions of four cancer cell lines of different tissue origins: SK-N-SH, HeLa, MCF-7 and MDA-MB-231, all for two different population densities: 50 K and 100 K cells/500 μL. The anticancer agent doxorubicin was applied for each cell type in order to investigate whether the proposed technique was able to determine specific differences in cell responses before and after drug treatment. The proposed methodology can offer valuable insight into the frequency-dependent bioelectrical responses of various cellular systems using a low frequency range and without necessitating lengthy cell culture treatment. The further development of this biosensor assembly with the integration of specially designed cell/electronic interfaces can lead to novel diagnostic biosensors and therapeutic bioelectronics.

Keywords: cancer cell lines; cell-based biosensor; doxorubicin; four-point probe measurements; polydimethylsiloxane.

MeSH terms

  • Biosensing Techniques*
  • Breast Neoplasms*
  • Cell Line, Tumor
  • Electric Impedance
  • Electrochemical Techniques
  • Female
  • Humans
  • MCF-7 Cells